290 related articles for article (PubMed ID: 23168774)
1. Revised terminology for cervical histopathology and its implications for management of high-grade squamous intraepithelial lesions of the cervix.
Waxman AG; Chelmow D; Darragh TM; Lawson H; Moscicki AB
Obstet Gynecol; 2012 Dec; 120(6):1465-71. PubMed ID: 23168774
[TBL] [Abstract][Full Text] [Related]
2. The terminology of pre-invasive cervical lesions in the UK cervical screening programme.
Herrington CS
Cytopathology; 2015 Dec; 26(6):346-50. PubMed ID: 26767601
[TBL] [Abstract][Full Text] [Related]
3. Role of the Biomarker p16 in Downgrading -IN 2 Diagnoses and Predicting Higher-grade Lesions.
Maniar KP; Sanchez B; Paintal A; Gursel DB; Nayar R
Am J Surg Pathol; 2015 Dec; 39(12):1708-18. PubMed ID: 26371784
[TBL] [Abstract][Full Text] [Related]
4. Two-grade Bethesda system of reporting in cervical screening: colposcopist's view.
Prendiville W
Cytopathology; 2015 Dec; 26(6):351-3. PubMed ID: 26767602
[No Abstract] [Full Text] [Related]
5. Effect of Lower Anogenital Squamous Terminology Recommendations on the Use of p16 Immunohistochemistry and the Proportion of High-Grade Diagnoses in Cervical Biopsy Specimens.
Thrall MJ
Am J Clin Pathol; 2016 Apr; 145(4):524-30. PubMed ID: 27124943
[TBL] [Abstract][Full Text] [Related]
6. The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology.
Darragh TM; Colgan TJ; Cox JT; Heller DS; Henry MR; Luff RD; McCalmont T; Nayar R; Palefsky JM; Stoler MH; Wilkinson EJ; Zaino RJ; Wilbur DC;
J Low Genit Tract Dis; 2012 Jul; 16(3):205-42. PubMed ID: 22820980
[TBL] [Abstract][Full Text] [Related]
7. HPV-related squamous neoplasia of the lower anogenital tract: an update and review of recent guidelines.
Maniar KP; Nayar R
Adv Anat Pathol; 2014 Sep; 21(5):341-58. PubMed ID: 25105936
[TBL] [Abstract][Full Text] [Related]
8. Utility of p16 Immunohistochemistry in Evaluating Negative Cervical Biopsies Following High-risk Pap Test Results.
Shain AF; Kwok S; Folkins AK; Kong CS
Am J Surg Pathol; 2018 Jan; 42(1):69-75. PubMed ID: 29112019
[TBL] [Abstract][Full Text] [Related]
9. [Nomenclature of squamous cell precursor lesions of the lower female genital tract : Current aspects].
Horn LC; Brambs CE; Handzel R; Mehlhorn G; Schmidt D; Schierle K
Pathologe; 2016 Nov; 37(6):526-533. PubMed ID: 27738814
[TBL] [Abstract][Full Text] [Related]
10. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
Zhang G; Yang B; Abdul-Karim FW
Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
[TBL] [Abstract][Full Text] [Related]
11. Relationships of p16 Immunohistochemistry and Other Biomarkers With Diagnoses of Cervical Abnormalities: Implications for LAST Terminology.
Castle PE; Adcock R; Cuzick J; Wentzensen N; Torrez-Martinez NE; Torres SM; Stoler MH; Ronnett BM; Joste NE; Darragh TM; Gravitt PE; Schiffman M; Hunt WC; Kinney WK; Wheeler CM; ;
Arch Pathol Lab Med; 2020 Jun; 144(6):725-734. PubMed ID: 31718233
[TBL] [Abstract][Full Text] [Related]
12. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies.
Dray M; Russell P; Dalrymple C; Wallman N; Angus G; Leong A; Carter J; Cheerala B
Pathology; 2005 Apr; 37(2):112-24. PubMed ID: 16028838
[TBL] [Abstract][Full Text] [Related]
13. Overdiagnosis of HSIL on cervical biopsy: errors in p16 immunohistochemistry implementation.
Clark JL; Lu D; Kalir T; Liu Y
Hum Pathol; 2016 Sep; 55():51-6. PubMed ID: 27134110
[TBL] [Abstract][Full Text] [Related]
14. The Lower Anogenital Squamous Terminology Standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology.
Darragh TM; Colgan TJ; Thomas Cox J; Heller DS; Henry MR; Luff RD; McCalmont T; Nayar R; Palefsky JM; Stoler MH; Wilkinson EJ; Zaino RJ; Wilbur DC;
Int J Gynecol Pathol; 2013 Jan; 32(1):76-115. PubMed ID: 23202792
[TBL] [Abstract][Full Text] [Related]
15. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
[TBL] [Abstract][Full Text] [Related]
16. Management of atypical squamous cells, low-grade squamous intraepithelial lesions, and cervical intraepithelial neoplasia 1.
Boardman LA; Kennedy CM
Obstet Gynecol Clin North Am; 2008 Dec; 35(4):599-614; ix. PubMed ID: 19061819
[TBL] [Abstract][Full Text] [Related]
17. Differences Between Squamous Intraepithelial Lesions of the Vulva and the Cervix.
Maclean AB; Jones RW
J Low Genit Tract Dis; 2020 Jul; 24(3):330-331. PubMed ID: 32501869
[TBL] [Abstract][Full Text] [Related]
18. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H].
Wu Y; Zhao J; Hu J; Wu XW; Zhu LR
Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):734-739. PubMed ID: 29179267
[No Abstract] [Full Text] [Related]
19. Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: cytohistologic correlation study with diagnostic pitfalls.
Mokhtar GA; Delatour NL; Assiri AH; Gilliatt MA; Senterman M; Islam S
Acta Cytol; 2008; 52(2):169-77. PubMed ID: 18499989
[TBL] [Abstract][Full Text] [Related]
20. Update on ASCCP consensus guidelines for abnormal cervical screening tests and cervical histology.
Apgar BS; Kittendorf AL; Bettcher CM; Wong J; Kaufman AJ
Am Fam Physician; 2009 Jul; 80(2):147-55. PubMed ID: 19621855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
